| Line item | 2025-01-31 FY | 2024-01-31 FY | 2023-01-31 FY | 2022-01-31 FY | 2021-01-31 FY |
|---|---|---|---|---|---|
| Revenue | $16.17K | $0.00 | $5.38K | $7.75K | $30.25K |
| Cost of Revenue | – | – | – | – | $5.61K |
| Gross Profit | – | – | $5.38K | $7.75K | $24.64K |
| Operating Expenses | $33.02K | $59.50K | $21.70K | $53.83K | -$44.15K |
| R&D | – | – | – | – | – |
| SG&A | $18.82K | $59.50K | $21.70K | $53.83K | -$44.15K |
| Operating Income | -$16.86K | -$59.50K | -$16.32K | $46.08K | -$19.51K |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | – | – | – |
| Net Income | -$31.15K | -$59.50K | -$44.44K | -$46.08K | -$19.51K |
| EPS (basic) | 0.0000 | 0.0100 | 0.0000 | 0.0000 | – |
| EPS (diluted) | – | 0.0100 | 0.0000 | – | – |
| Shares (diluted) | – | $20.30M | $19.00M | – | $3.05M |